Stem Cell Therapy Market 2019 Global Trends, Size, Share, Status, SWOT Analysis and Forecast to 2025
Jul 9, 2019
MarketStudyReport.com Adds New Stem Cell Therapy Market 2019 – 2025 research report providing information and data By Type, By Application, By End-users, Industry Analysis, Regional Outlook, Technology Potential, Competitive Market Share & Forecast spreading across 130 Pages with table and figures in it.
Delaware, Selbyville - July 9, 2019 /MarketersMedia/ —
Europe is anticipated to witness around 10% growth during analysis time frame. Substantial growth is attributed to increasing prevalence of chronic diseases in the region. Moreover, the regulatory scenario for stem cell therapies is also improving gradually. Initially stringent regulations lowered the demand for stem cell therapies. However, as people started becoming aware regarding advantages associated with stem cell therapy, its adoption escalated. Above-mentioned factors foster the regional growth.
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/2100692/
Rising geriatric population will positively influence the industry growth in coming years. Elderly people are susceptible to degenerative diseases such as Parkinson’s and Alzheimer’s disorders. Stem cell therapies offer several benefits over the conventional therapeutic methods that raises its preference for curing degenerative diseases. Recently developed stem cell therapies generate healthy cells by replacing the defective cells through minimally invasive techniques. Therefore, geriatric population rely on stem cell therapies that proves beneficial for the industry growth.
Stem Cell Therapy Market will exceed USD 15 billion by 2025. Increasing research on developing novel therapies and personalized medicines will foster stem cell therapy market growth. For instance, scientists are extensively researching on methods to regenerate healthy heart cells from placenta that can be used in patients after myocardial infarction. This discovery will help to cure patients suffering from cardiovascular diseases and reduce mortality rates. Researchers are further examining different aspects of stem cell therapy for its applications in neurological disorders. Thus, increasing R&D activities to promote developments in stem cell therapy will positively impact the industry growth.
Orthopedic segment is anticipated to witness more than 9% growth over the forecast time frame. Substantial growth is attributed to rising accidents and trauma cases across the globe. Stem cell therapy is successfully applicable in treating bone-joint injuries that include spinal and fractured bone defects, ligament tendon, femoral head and osteogenesis imperfecta. Mesenchymal stem cell therapy is preferred in curing orthopedic diseases such as arthritis and osteoporosis due to its ability to differentiate into bones and cartilage. Above mentioned factors will surge segment growth.
Allogenic stem cell therapy segment was valued around USD 3 billion in 2018 and is anticipated to expand substantially in near future. Allogenic transplant completely replaces host cells with donor cells. It also has the potential to eliminate viral reservoirs and genetic alterations. Therefore, allogenic stem cell therapies have been extensively utilized in providing treatment to patients suffering from leukemia and several other life-threatening diseases. Thus, benefits offered by allogenic stem cell therapy will surge its demand, thereby propelling segment growth.
Clinics segment accounted for around 35% revenue share in 2018. Clinics are equipped with advanced medical equipment and skilled professionals that enables it to provide superior quality stem cell therapies. Clinics can deliver specialized stem cell treatment in areas such as cardiovascular, oncology or orthopedics that should prove beneficial for the segmental growth. However, as the treatments offered at clinics are expensive, that may have a short-term impact on the segment growth.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/2100692/
Prominent industry players operational in the stem cell therapy include Astellas Pharma, Cellectis, Celyad, ReNeuron Group, Gamida Cell, Capricor Therapeutics, Cellular Dynamics, Novadip Biosciences, CESCA Therapeutics, DiscGenics, OxStem, Mesoblast, and Takeda Pharmaceuticals. These key players adopt several initiatives such mergers, acquisitions and new product launches to sustain market position. Besides these strategies, companies also undertake promotional strategies that enhance their sales. For instance, in June 2018, CESCA Therapeutics announced exhibition at Orthobiologic Institute?s ninth annual PRP and regenerative medicine symposium. This strategy was company?s promotional effort in order to gain attention of customers.
Table of Content:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Stem Cell Therapy Industry Insights
Chapter 4. Stem Cell Therapy Market, By Type
Chapter 5 Stem Cell Therapy Market, By Application
Chapter 6 Stem Cell Therapy Market, By End-users
Chapter 7. Stem Cell Therapy Market, By Region
Chapter 8. Company Profiles
More Details on this Report At: https://www.marketstudyreport.com/reports/stem-cell-therapy-market
Related Report: -
Global Canine Stem Cell Therapy Market Size, Status and Forecast 2019-2025
The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic stem cell therapy is 100% safe, which further supports its demand on a global level. Pet owners are identified to prefer allogeneic stem cell therapy over autologous therapy, attributed to its relatively lower costs and comparative ease of the entire procedure.
About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910
Website: https://www.marketstudyreport.com
Source: MarketersMedia
Release ID: 88894155
More News
America’s billionaires are turning their backs on Trump
The US president’s loss of political momentum has given some of his backers the cover to start talking their mind.
We are crusading against things that would keep us safe – like data centres
AI regulation will weaken us while data centres protect us.
Steel, concrete and coffee: The new look for cyclists
MAAP’s new store features an organic-shaped lounge suite, coffee table stacked with books and magazines, espresso machine and a screen showing cycling races the world over.
Rack and ruin: Australian fashion is going through its own spring cleaning
After Dion Lee, Seafolly and Betts Shoes, Cue and Veronika Maine are the latest to join a growing list of well-known fashion retailers or brands that no longer exist in their original form.
Not OK, Boomers? The repercussions of a generation on its way out
Baby Boomers, who entered the world in an optimistic postwar birth rate explosion, are heading into their 80s and starting to exit the world.
Australian shares limp ahead to end four-week losing streak
Investor confidence remains shaky as inflation, interest rates and a challenging earnings environment loom.
Big Hits: Solstice Minerals, Kantra Copper and Brazilian Rare Earths
Bulls N’ Bears Big Hits looks at notable drill intercepts reported to the ASX last week, led by Solstice Minerals in WA, with runners-up Kantra Copper and Brazilian Rare Earths.
The Iran war is making Australia’s gas industry richer
Soaring LNG prices are set to reverse a forecast revenue slump, delivering an unexpected $23 billion boost to the nation’s biggest gas exporters.
ASX Runners of the Week: Dateline, Mamba, Image Resources & BOA
The Bulls N’ Bears ASX Runner of the Week is… Dateline Resources, which more than doubled after the US Government intervened in a legal stoush to restart its Californian gold and rare earths project.
ANZ drops KPMG from audit job as accounting body fails to land a hit
KPMG has already cut hundreds of staff after it botched the handling of a whistleblower scandal, which has led to the departure of another major client.
Patriot puts 3km Peru silver corridor under microscope
Patriot Resources has kicked off a major exploration push at its Tassa project in Peru, aiming to grow its 31.4-million-ounce silver-equivalent resource after first samples went to the lab.
13-year-long bribery investigation by AFP ends with no prosecution
A storied Australian engineering giant that originated with the Snowy Hydro scheme and still has government contracts paid $9 million as part of the settlement.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.